EUVIMEDEUVIMED entdecken
Crossref

Instant Non Invasive Health Monitoring System With Glucose Monitoring.

asha Gopan G P, magesh Rajasekaran, sadhana Rajasekhar, suhail Aamir A, ananthakumar P K

International Journal of Drug Delivery Technology · 09.04.2026 · 16 (6s)

DOI: 10.25258/ijddt.16.6s.7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 09.04.2026. Verfasst von asha Gopan G P und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Heart failure is the leading cause of morbidity and mortality and it affects multiple organs and systems. Liver failure and dysfunction is one of the common and major complications of HF. Angiotensin Receptor Neprilysin Inhibitor (ARNI) signifies the paradigm shift in the treatment of HF and it is shown to reduce the mortality and morbidity in Heart failure (HF) patients. But worries about the possible hepatotoxicity of ARNI have been arised, particularly in patients with preexisting liver disease. Hence this present study is undertaken to assess the efficacy of ARNI on measures of liver function in patients with HFrEF compared to conventional therapy Materials and Methods This is a cross-sectional study. Around 65 patients with heart failure with reduced ejection fraction were recruited after obtaining informed consent and institutional ethical clearance. Patients with Symptomatic hypotension, estimated glomerular filtration rate < 30 mL/min/1.73 m2 ,history of serious side effects during treatment with ACEI or ARB,Patients with aspartate aminotransferase (AST) or alanine aminotransferase (ALT) exceeding twice the upper limit of normal, history of hepatic encephalopathy, oesophageal varices, or portacaval shunt were excluded from this study.

Results

In the present study showed that total bilirubin, AST, ALT, ALP, creatinine mean value is less in ARNI group compared to those who are not on ARNI. MELD – XI score was reduced in patients with ARNI treatment and it was found to be statistically significant (p=0.04).

Conclusion

Liver parameters and MELD – XI score was found to be better in HF patients with ARNI treatment when compared with patients without ARNI treatment. In conclusion, ARNI treatment is found to be beneficial for heart as well as liver parameters

Zitieren

APA

P, A. G. G., Rajasekaran, M., Rajasekhar, S., A, S. A., & K, A. P. (2026). Instant Non Invasive Health Monitoring System With Glucose Monitoring. International Journal of Drug Delivery Technology, 16(6s). https://doi.org/10.25258/ijddt.16.6s.7

Vancouver

P AGG, Rajasekaran M, Rajasekhar S, A SA, K AP. Instant Non Invasive Health Monitoring System With Glucose Monitoring. International Journal of Drug Delivery Technology. 2026;16(6s). doi:10.25258/ijddt.16.6s.7

BibTeX
@article{P2026,
  author = {P, asha Gopan G and Rajasekaran, magesh and Rajasekhar, sadhana and A, suhail Aamir and K, ananthakumar P},
  title = {Instant Non Invasive Health Monitoring System With Glucose Monitoring},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {6s},
  doi = {10.25258/ijddt.16.6s.7}
}
Kostenlos starten →